Sutro Biopharma Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $6.13 on 03/28/24, and the lowest price during the same period was recorded at $2.06 on 11/27/23.
52-week price history of STRO Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Sutro Biopharma Inc’s current trading price is -43.72% away from its 52-week high, while its distance from the 52-week low is 67.48%. The stock’s price range during this period has fluctuated between $2.06 and $6.13. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.7 million for the day, which was evidently higher than the average daily volume of 0.6 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Sutro Biopharma Inc (STRO) has experienced a quarterly decline of -18.05% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 282.78M and boasts a workforce of 302 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.81, with a change in price of +0.46. Similarly, Sutro Biopharma Inc recorded 668,007 in trading volume during the last 100 days, posting a change of +15.38%.
STRO Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for STRO stands at 1.77. Similarly, the long-term debt-to-equity ratio is also 1.70.
STRO Stock Stochastic Average
The raw stochastic average for Sutro Biopharma Inc over the last 50 days is presently at 14.56%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 16.67%. Further, the company’s Stochastic %K and %D values for the last 20 days were 44.20% and 63.94%, respectively.
STRO Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price loss of -19.58% this year. Over the last six months, there has been a stronger performance of -16.87%. The price of STRO leaped by -8.49% during the last 30 days period. For the last 5-days stocks have slided -17.07%.
